The Board proposes the rule amendment to remove the requirement for applicants by examination to have completed an HIV/AIDS course as part of the application.  


  • RULE NO: RULE TITLE
    64B16-26.203: Licensure by Examination; Application
    PURPOSE AND EFFECT: The Board proposes the rule amendment to remove the requirement for applicants by examination to have completed an HIV/AIDS course as part of the application.
    SUMMARY: The requirement for applicants by examination to have completed an HIV/AIDS course as part of the application will be removed from the rule.
    SUMMARY OF STATEMENT OF ESTIMATED REGULATORY COSTS: No Statement of Estimated Regulatory Cost was prepared.
    Any person who wishes to provide information regarding a statement of estimated regulatory costs, or provide a proposal for a lower cost regulatory alternative must do so in writing within 21 days of this notice.
    SPECIFIC AUTHORITY: 456.033, 465.005 FS.
    LAW IMPLEMENTED: 456.013(1), (7), 456.025(3), 456.033, 465.007, 465.022 FS.
    IF REQUESTED WITHIN 21 DAYS OF THE DATE OF THIS NOTICE, A HEARING WILL BE SCHEDULED AND ANNOUNCED IN FAW.
    THE PERSON TO BE CONTACTED REGARDING THE PROPOSED RULE IS: Rebecca R. Poston, Executive Director, Board of Pharmacy/MQA, 4052 Bald Cypress Way, Bin #C04, Tallahassee, Florida 32399-3253

    THE FULL TEXT OF THE PROPOSED RULE IS:

    64B16-26.203 Licensure by Examination; Application.

    Applicants who are at least 18 years of age and a recipient of a degree from a school or college of pharmacy accredited by an accrediting agency recognized and approved by the United States Offices of Education may apply to take the licensure examination.

    (1) No change.

    (2) The applicant must submit proof of having met the following requirements:

    (a) No change.

    (b) Completion of an HIV/AIDS course of no less than 3 contact hours covering the subject listed in Rule 64B16-26.602, F.A.C. For those applicants who apply within one year following receipt of their pharmacy degree, completed academic course work on HIV/AIDS will be accepted by the Board as an education course under this section, provided such course work is no less than 3 contact hours and that it covers the subjects listed in Rule 64B16-26.601, F.A.C., as evidenced by a letter attesting to subject matter covered from the Dean of the University.

    (b)(c)  No change.

    (3) through (4) No change.

    Specific Authority 456.033, 465.005 FS. Law Implemented 456.013(1), (7), 456.025(3), 456.033, 465.007, 465.022 FS. History– New 10-17-79, Formerly 21S-12.04, 21S-12.004, Amended 7-31-91, 10-14-91, Formerly 21S-26.203, 61F10-26.203, Amended 7-1-97, Formerly 59X-26.203, Amended 8-17-99, 10-15-01, 1-2-02, 1-12-03, 1-11-05,_________.


    NAME OF PERSON ORIGINATING PROPOSED RULE: Board of Pharmacy
    NAME OF SUPERVISOR OR PERSON WHO APPROVED THE PROPOSED RULE: Board of Pharmacy
    DATE PROPOSED RULE APPROVED BY AGENCY HEAD: April 24, 2007
    DATE NOTICE OF PROPOSED RULE DEVELOPMENT PUBLISHED IN FAW: May 25, 2007

Document Information

Comments Open:
12/28/2007
Summary:
The requirement for applicants by examination to have completed an HIV/AIDS course as part of the application will be removed from the rule.
Purpose:
The Board proposes the rule amendment to remove the requirement for applicants by examination to have completed an HIV/AIDS course as part of the application.
Rulemaking Authority:
456.033, 465.005 FS.
Law:
456.013(1), (7), 456.025(3), 456.033, 465.007, 465.022 FS.
Contact:
Rebecca R. Poston, Executive Director, Board of Pharmacy/MQA, 4052 Bald Cypress Way, Bin #C04, Tallahassee, Florida 32399-3253
Related Rules: (1)
64B16-26.203. Licensure by Examination; Application